Hookipa Pharma Inc

$11.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.27%) Today
$0.00 (0.00%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell HOOK and other stocks, options, and ETFs commission-free!

About HOOK

HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its product includes VaxWace and TheraT. The company was founded by Rolf Zinkernagel, Andreas Bergthaler, Lukas Flatz, Katherine Cohen, and Daniel Pinschewer in 2011 and is headquartered in New York, NY. The listed name for HOOK is HOOKIPA Pharma Inc. Common Stock.

CEO
Jörn Aldag
Employees
104
Headquarters
New York, New York
Founded
2011
Market Cap
284.17M
Price-Earnings Ratio
Dividend Yield
Average Volume
40.70K
High Today
$11.59
Low Today
$11.06
Open Price
$11.06
Volume
28.67K
52 Week High
$14.37
52 Week Low
$5.80

Collections

HOOK Earnings

-$9.27
-$6.18
-$3.09
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 18, Pre-Market

You May Also Like